Exjade 125 mg (Deferasirox TABLET FOR SUSPENSION) 125 MG

EXJADE 125 MG is a tablet for suspension used for managing iron overload. This medication, containing deferasirox, helps in reducing excess iron in the body. Ideal for those requiring iron chelation therapy.

Strength

125 MG

Pack Size

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

EXJADE 125 MG is primarily used for the treatment of chronic iron overload due to blood transfusions. This medication is designed to bind excess iron and help the body eliminate it. It is often prescribed for conditions where the body accumulates too much iron, such as in certain anemia treatments. What is EXJADE used for? It is used to manage iron overload in patients who receive frequent blood transfusions.

Side Effects

Common effects of EXJADE 125 MG may include gastrointestinal issues like nausea, vomiting, or diarrhea. Some users might experience skin rashes or changes in kidney function. It is important to monitor for any adverse reactions and consult a healthcare provider if concerns arise.

Precautions & Warnings

EXJADE 125 MG should be used with caution in patients with kidney or liver problems. Regular monitoring of kidney function and blood counts is recommended. Avoid taking this medication if you are allergic to deferasirox or any of its components. Always follow the advice of a healthcare professional regarding its use.

Avoid Interactions

EXJADE 125 MG may interact with certain medications, including those metabolized by the liver. It is important to inform your healthcare provider about all medications you are taking, including over-the-counter drugs and supplements. Avoid taking antacids within an hour of taking EXJADE, as they can affect its absorption.

Frequently Asked Questions

EXJADE 125 MG is used to manage iron overload in patients who receive frequent blood transfusions.

EXJADE 125 MG is a tablet for suspension that should be taken orally, typically once daily.

Common side effects may include gastrointestinal issues like nausea, vomiting, or diarrhea, as well as skin rashes.

EXJADE 125 MG may interact with certain medications, so it is important to consult a healthcare provider before combining it with other drugs.

Patients with known allergies to deferasirox or those with severe kidney or liver problems should avoid taking EXJADE 125 MG.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.